AI assistant
INCYTE CORP — Director's Dealing 2023
Jul 18, 2023
30371_dirs_2023-07-18_42bd2321-c512-4d6d-8d68-18c9c19c01c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2023-07-14
Reporting Person: Iyengar Vijay K (EVP, GMAPPS)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Common Stock | A | 7089 | $0.00 | Acquired | 44069 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-07-14 | Employee Stock Option (right to buy) | $61.76 | A | 14868 | Acquired | 2033-07-13 | Common Stock (14868) | Direct |
Footnotes
F1: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Vijay Iyengar's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2: Including the July 14, 2023 RSU Grant, this includes an aggregate of 31,156 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
F3: The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.